Mostrar el registro sencillo del ítem

dc.contributorCells For Cells S. A.es_ES
dc.contributor.advisorPATRICIA VERONICA DAUELSBERG TANNENBAUMes_ES
dc.date2012-10-11es_ES
dc.date.accessioned2013-11-22T17:20:12Z
dc.date.available2018-06-12T08:15:21Z
dc.date.issued2013-11-22
dc.identifier2012-16825-INNOVA_PRODUCCIONes_ES
dc.identifier2012-16825es_ES
dc.identifier.urihttp://repositoriodigital.corfo.cl/handle/11373/8558
dc.descriptionGenerate Capabilities On R&d Result's Commercialization And Business Strategy Within C4c's Managers And Lead Researchers.es_ES
dc.descriptionGenerate Networking Between C4c Team And Foreign Worldwide Tech Brokers Vc's Investors And Scientists With Market Skills.es_ES
dc.descriptionPut Menstrual Stem Cells New Applications Into the Marketes_ES
dc.descriptionSupport And Strenghten Business Strategy Of Menstrual Stem Cells Novel Market Oriented Applications.es_ES
dc.description.abstractThe Product We Are Presenting is a Novel Source Of Stem Cells Derived From Menstrual Fluid. Although This Source Was First Reported In 2007 the Properties Of the Menstrual Cells (menscs) And Their Potential As a Therapeutic Benefit For a Group Of Diseases Are Very Wide And Still Undiscovered. Therefore the Field For Finding New Market Applications (therapeutic And Cosmetic) As Well As For Optimizing And Scaling-up Production Processes And Delivery Methods is Still a Huge R&d And Market Opportunity. Worldwide Menstrual Stem Cells Products Or Therapies Have Not Reached the Market Yet. In Addition Menscs Non-invasive And Relatively Constant (women s Fertility Cycle) Recovery Process is An Advantage Over Other Adult Stem Cells Sources Such As Bone Marrow. Menscs Are Free Of Ethical Dilemmas Are a Periodic And Non-invasive Source For Cells Recovery Neither Medical Nor Surgery Procedures Are Required For Sample Collection Thus All Of These Aspects Can Reduce the Product Costs And Ethical Issues: Traditionally the Main Barriers To Reach the Market. However More R&d And Clinical Trials Are Required Since Every Stem Cell Application is Unique And Must Be Clinically Proven For Every Specific Cell s Source And Disease In Terms Of Safety And Efficiency. Most Likely Usages To Start With Are Cosmetics Applications Using Autologous Stem Cells Regenerative Properties Such As Anti-ageing And Skin Regeneration For Brown Stains Caused By Sun Exposure. Long-term Developments Include the Treatment Of Other Severe Immune Diseases Using Injection Of Either Autologous Or Allogeneic Cells. Currently Cell For Cells Inc (c4c) is Working On Several R&d Projects Related To the Development Of Menstrual Stem Cells (menscs) New Applications Based On Their Immunomodulatory And Regenerative Properties. During October 2012 C4c Will File Two Patent Applications On Menscs. Therefore This go To Market Proposal is Aimed To Strengthen the C4c s Menscs Business Plan And Commercialization Strategy In Order To Boost This Technology Into Chilean As Well As Global Markets Starting With Simplest And Less Controversial Applications.es_ES
dc.description.sponsorshipCorporación de Fomento de la Producciónes_ES
dc.titleStem Cell Population From Menstrual Fluids And Their Potential Application In Inflammatory Diseaseses_ES
dc.typeproyectoes_ES
cf.beneficiario.actividadeconomicaVenta al por mayor de otros productos N.C.P.es_ES
cf.beneficiario.razonsocialCells For Cells S. A.es_ES
cf.beneficiario.rut76119385-6es_ES
cf.beneficiario.tamanoempresaMicro Empresaes_ES
cf.beneficiario.tipoparticipanteBeneficiarioes_ES
cf.beneficiario.tipopersonaJurídicaes_ES
cf.comite.fecha2012-11-06es_ES
cf.comite.nombreCOMITE INNOVAes_ES
cf.costo.beneficiarioaprobado5200000es_ES
cf.costo.corfoaprobado43700000es_ES
cf.costo.corforeal43700000es_ES
cf.costo.tipomonedaPESO CHILENOes_ES
cf.ejecutivo.nombrePATRICIA VERONICA DAUELSBERG TANNENBAUMes_ES
cf.ejecutivo.rut131911963es_ES
cf.fecha.inicio2012-10-11es_ES
cf.fecha.postulacion2012es_ES
cf.fecha.termino2013-10-08es_ES
cf.proyecto.estadoTerminadoes_ES
cf.proyecto.instrumentoGo To Market 2.0es_ES
cf.proyecto.tipopostulacionIndividuales_ES
cf.proyecto.unidadorigenInnovaes_ES
cf.region.postulacionRM Santiagoes_ES
cf.region.ejecucionRM Santiagoes_ES
cf.region.impactoRM Santiagoes_ES
cf.costo.beneficiarioreal5200000es_ES


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem